The radionuclide used for imaging in the diagnostic assessment of prostate cancer is
A) (99m) Tc-sestamibi.
B) (99m) Tc-arcitumomab.
C) (111) In-capromab pendetide.
D) (111) In-pentetreotide.
Correct Answer:
Verified
Q4: A technologist is positioning a patient for
Q5: A 67Ga image at 48 hours after
Q6: A patient arrives in a nuclear medicine
Q7: How many radionuclides are currently approved by
Q8: A patient's indication for a nuclear medicine
Q10: In imaging with 67Ga-citrate, target-to-background ratio increases
Q11: A technologist is performing a parathyroid study
Q12: Patient preparation for an 111In-capromab pendetide imaging
Q13: Among the safety instructions a technologist will
Q14: The radionuclide used to visualize primary neuroendocrine
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents